论文部分内容阅读
目的研究分析马来酸曲美布汀与谷维素联合用药治疗肠易激综合征患者的临床效果。方法选取我院于2011年3月至2012年1月收治的77例肠易激综合征患者的临床资料,将其按照住院号尾号的奇偶分为治疗组和对照组,治疗组37例患者采用药物联合治疗,即马来酸曲美布汀联合谷维素治疗。对照组40例患者采用马来酸曲美布汀单独用药,两组患者均治疗一个月,对比两组患者治疗效果。结果两组患者治疗有效率对比,差异有统计学意义(P<0.05);两组患者治疗后各临床症状改善,治疗组优于对照组,有统计学意义(P<0.05);两组不良反应率对比,P>0.05为差异无统计学意义。结论肠易激综合征采用马来酸曲美布汀联合谷维素联合治疗,可以改善患者的临床症状,安全有效,值得推广。
Objective To study the clinical effect of trimebutine maleate and oryzanol in the treatment of patients with irritable bowel syndrome. Methods The clinical data of 77 patients with IBS admitted from March 2011 to January 2012 in our hospital were divided into the treatment group and the control group according to the odd-even number of the tail number of hospitalization, and 37 patients in the treatment group The drug combination therapy, trimebutine maleate with oryzanol treatment. Control group, 40 patients treated with trimebutine maleate alone, both patients were treated for one month, compared two groups of patients with treatment. Results The two groups of patients with treatment efficiency, the difference was statistically significant (P <0.05); two groups of patients after treatment to improve the clinical symptoms, the treatment group was better than the control group, with statistical significance (P <0.05); two groups of poor Response rate comparison, P> 0.05 for the difference was not statistically significant. Conclusion Irritable bowel syndrome using trimebutine maleate combined with oryzanol combined treatment can improve the clinical symptoms of patients, safe and effective, it is worth promoting.